Christie Matthew
Queen Alexandra Hospital, Portsmouth Hospitals University NHS Trust, Cosham, Portsmouth PO6 3LY, United Kingdom.
BJR Open. 2024 Aug 20;6(1):tzae021. doi: 10.1093/bjro/tzae021. eCollection 2024 Jan.
Augmented reality (AR) exists on a spectrum, a mixed reality hybrid of virtual projections onto real surroundings. Superimposing conventional medical imaging onto the living patient offers vast potential for radiology, potentially revolutionising practice. The digital technology and user-interfaces that allow us to appreciate this enhanced environment however are complex, expensive, and development mainly limited to major commercial technology (Tech) firms. Hence, it is the activity of these consumer-based businesses that will inevitably dictate the available technology and therefore clinical application of AR. The release of mixed reality head-mounted displays in 2024, must therefore prompt a review of the current status of AR research in radiology, the need for further study and a discussion of the complicated relationship between consumer technology, clinical utility, and the risks of monopolisation.
增强现实(AR)处于一个连续体上,是将虚拟投影叠加到真实环境中的混合现实。将传统医学成像叠加到活体患者身上为放射学提供了巨大潜力,有可能彻底改变实践。然而,使我们能够体验这种增强环境的数字技术和用户界面复杂、昂贵,且开发主要局限于大型商业科技公司。因此,这些基于消费者的企业的活动将不可避免地决定可用技术,进而决定AR的临床应用。因此,2024年混合现实头戴式显示器的发布,必须促使人们审视放射学中AR研究的现状、进一步研究的必要性,并讨论消费技术、临床效用和垄断风险之间的复杂关系。